Abstract
Consideration of fertility-sparing options in the management of ovarian cancer is an increasing concern for gynecological oncologists. For various reasons, women are continuing to delay having children until later years when they may be more at risk of developing ovarian cancer. Preserving fertility in the presence of ovarian cancer diagnosis is a difficult scenario for all involved and creates a balancing act between patients’ sometimes desperate wishes and maintaining safe clinical practice. There is obvious difficulty in researching the impact of fertility-sparing surgery and alternative treatments for ovarian cancer, as a prospective analysis would be unethical; however, retrospective reviews of cases have been performed to aid guidelines regarding safest management options. We will consider the options available to patients who wish to preserve their fertility and the international guidance depending on types of cancer and method of treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Del Mastro L, et al. Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. Cancer Treat Rev. 2014;40(5):675–83.
Duncan FE, Jozefik JK, Kim AM, Hirshfeld-Cytron J, Woodruff TK. The gynecologist has a unique role in providing oncofertility care to young cancer patients. US Obstet Gynecol. 2011;6(1):24–34.
Fotopoulou C, Schumacher G, Schefold JC, Denkert C, Lichtenegge W, Sehouli J. Systematic evaluation of the intraoperative tumor pattern in patients with borderline tumor of the ovary. Int J Gynecol Cancer. 2009;19(9):1550–5.
Fotopoulou C, Braicu I, Sehouli J. Fertility-sparing surgery in early epithelial ovarian cancer: a viable option? Obstet Gynecol Int. 2012;2012:238061. https://www.rcog.org.uk/globalassets/documents/guidelines/1.2.13-sip35-fertility-sparing.pdf
Kajiyama H, Shibata K, Mizuno M, et al. Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery. Br J Cancer. 2011;105(9):1288–94.
Liu D, Cai J, Gao A, et al. Fertility sparing surgery vs radical surgery for epithelial ovarian cancer: a meta-analysis of overall survival and disease-free survival. BMC Cancer. 2020;20:320.
Mangili G, Sigismondi C, Lorusso D, et al. Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience. Gynecol Oncol. 2011;121(2):280–4.
Rasool N, Rose PG. Fertility-preserving surgical procedures for patients with gynecologic malignancies. Clin Obstet Gynecol. 2010;53(4):804–14.
Satoh T, Hatae M, Watanabe Y, et al. Outcomes of fertility sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J Clin Oncol. 2010;28(10):1727–32.
SEER cancer statistics factsheets: ovary cancer. Bethesda: National Cancer Institute. 2015–2018. https://seer.cancer.gov/statfacts/html/ovary.html
William Helm C, Harris JE. Ovarian cancer staging. 2015. http://emedicine.medscape.com/article/2007140-overview
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Springer Nature Switzerland AG
About this entry
Cite this entry
Nixon, K., Fotopoulou, C. (2023). Fertility-Sparing Treatment for Ovarian Cancer. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-031-14881-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-031-14881-1_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-14880-4
Online ISBN: 978-3-031-14881-1
eBook Packages: MedicineReference Module Medicine